References

1 Sugio K, Molberg K, Albores-Saavedra J, Virmani AK, Kashimoto Y, Gazdar AF: K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers. Int J Pancreatol

1997;21:205-217.

2 Yamano M, Fujii H, Takagi T, Kadowaki N, Watanabe H, Shirai T: Genetic progression and divergence in pancreatic carcinoma. Am J Pathol 2000;156:2123-2133.

Klimstra DS, Longnecker DS: K-ras mutations in pancreatic ductal proliferative lesions. Am J Pathol 1994;145:1547-1550.

Hruban RH, Adsay NV Albores-Saavedra J, Compton C, Garrett ES, Goodman SN, Kern SE, Klimstra DS, Klöppel G, Longnecker DS, Lüttges J, Offerhasus JA: Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001;25:579-583.

Hruban RH, Takaori K, Klimstra DS, Adsay NV Albores-Saavedra J, Fukushima N, Furukawa T, Goggins M, Kato Y, Klöppel G, Longnecker DS, Lüttges J, Maitra A, Offerhaus JA, Shimizu M, Yonezawa S: An illustrated consensus on classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004;28:977-987. Andea A, Sarker F, Aday NV: Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analyses of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod Pathol 2003;16:996-1000.

Seidel G, Zahurak M, Iacobuzio-Donahue CA, Sohn TA, Adsay NV Yeo CJ, Lillemoe KD, Cameron JL, Hruban RH, Wilentz RB: Almost all infiltrating colloid carcinomas of the pancreas and periampullary region arise from in situ papillary neoplasm: a study of 39 cases. Am J Surg Pathol 2002;26:56-63.

Hruban RH, Goggins M, Parsons J, Kern SE: Progression model for pancreatic cancer. Clin Cancer Res 2000;6:2969-2971.

Biankin AV, Kench JG, Dijkman FP, Biankin SA, Henshall SM: Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma. Pathology 2003;35:14-24. Biankin AV, Biankin SA, Kench JG, Morey AL, Lee C-S, Head DR, Eckstein RP, Hugh TB, Henshall SM, Sutherland RL: Aberrant p16INK4A and DPC4/Smad4 expression in intraductal papillary mucinous tumors of the pancreas is associated with invasive ductal adenocarcinoma. Gut 2002;50:861-868.

Albores-Saavedra J, Wu J, Crook T, Amirkhan RH, Jones L, Hruban RH: Intestinal and oncocytic variants of pancreatic intraepithelial neoplasia. A morphological and immunohistolochemical study. Ann Diagn Pathol 2005;9:69-76.

Moskaluk CA, Hruban RH, Kern SE: p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1997;57:2140-2143.

Brockie E, Anan A, Albores-Saavedra J: Progression of atypical ductal hyperplasia carcinoma in situ of the pancreas to invasive adenocarcinoma. Ann Diagn Pathol 1998;2:286-292. Brat DJ, Lillemoe KD, Yeo CJ, Warfield PB, Hruban RH: Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol 1998;22:163-169. Matsukuma S, Suda K: Small pancreatic adenocarcinomas: clinicopathological analysis with immunohistochemical and histochemical evaluation. Pathol Int 1996;46:581-588. Milchgrub S, Campuzano M, Casillas J, Albores-Saavedra J: Intraductal carcinoma of the pancreas. Cancer 1992;69:651-656.

Yamano M, Fujii H, Takagi T, Kadowaki N, Watanabe H, Shirai T: Genetic progression and divergence in pancreatic carcinoma. Am J Pathol 2000;156:2123-2133.

Japan Pancreas Society: General Rules for the Study of Pancreatic Cancer (in Japanese), ed 5, revised. Tokyo, Kanahara, 2002.

Japan Pancreas Society: Classification of Pancreatic Cancer, first English edition. Tokyo, Kanahara, 2002.

Fukushima N, Mukai K, Sakamoto M, Hasebe T, Shimada K, Kosuge T, Kinoshita T, Hirohashi S: Invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical stydy of eight cases. Virchows Arch 2001;439; 6-13.

Maire F, Hammel P, Terris B, Paye F, Scoazec JY, Cellier C, Barthet M, O'Toole D, Rufat P, Partensky C, Cuillerier E, Levy P, Belghiti J, Ruszniewski P: Prognosis of malignant intraductal papillary mucinous tumors of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut 2002;51:717-722.

Adsay NV, Conlon KC, Zee SY, Brennan MF, Klimstra DS: Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer 2002;94;62-77.

23 Hruban RH, van Mansfeld ADM, Offerhaus GJA, van Weering DHJ, Alison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL: K-ras oncogene activation in adenocarcinoma of the human pancreas: a study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993;143: 545-554.

24 Wilentz WE, Goggins M, Redston M, Marcus VA, Adsay NV, Sohn TA, Kadkol SS, Yeo CJ, Choti M, Zahurak M, Johnson K, Tascilar M, Offerhaus GJA, Hruban RH, Kern SE: Genetic, immuno-histochemical, and clinical features of medullary carcinomas of the pancreas: a newly described and characterized entity. Am J Pathol 2000;156:1641-1651.

25 Maitra A, Kern SE, Hruban RH: Molecular pathogenesis of pancreatic cancer. Best Pract Res Clin Gastroenterol 2006;20:211-226.

26 Lüttges J, Schlehe B, Menke MAOH, Vogel I, Henne-Bruns D, Klöppel G: The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Cancer 1999;85:1703-1710.

27 Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, Moskaluk CA, Hahn SA, Schwarte-Waldhoff I, Schmiegal W, Baylin SB, Kern SE, Herman JG: Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 1997;57: 3126-3130.

28 Redston MS, Caldas C, Seymour AB, Hruban RH, da Costa L, Yeo CJ, Kern SE: p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res 1994;54:3025-3033.

29 Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fisher A, Yeo CJ, Hruban RH, Kern SE: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271:350-353.

30 Goggins M, Offerhaus GJ, Hilgers W, Griffin CA, Shekher M, Tang D, Sohn TA, Yeo CJ, Kern SE, Hruban RH: Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am J Pathol 1998;152:1501-1507.

31 Wilentz RE, Goggins M, Redston M, Marcus VA, Adsay NV, Sohn TA, Kadkol SS, Yeo CJ, Chiti M, Zahrak M, Johnson K, Tascilar M, Offerhaus GJ, Hruban RH, Kern SE: Genetic, immunohisto-chemical, and clinical features of medullary carcinoma of the pancreas: a newly described and characterized entity. Am J Pathol 2000;156:1641-1651.

32 Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen GM, Yeo CJ, Jackson CE, Lynch HT, Hruban RH, Kern SE: Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 1996;56:5360-5364.

33 Murphy KM, Brune KA, Griffin C, Sollenberger JE, Petersen GM, Bansal R, Hruban RH, Kern SE: Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res 2002;62:3789-3793.

34 van Heek NT, Meeker AK, Kern SE, Yeo CJ, Lillemoe KD, Cameron JL, Offerhaus GJ, Hicks JL, Wilentz RE, Goggins MG, De Marzo AM, Hruban RH, Maitra A: Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am J Pathol 2002;161:1541-1547.

35 Iacobuzio-Donahue CA, Ashfaq R, Maitra A, Adsay NV, Shen-Ong GL, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M, Hruban RH: Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 2003;63:8614-8622.

Bunsei Nobukawa, MD, PhD

Department of Human Pathology, Juntendo University School of Medicine 2-1-1, Hongo, Bunkyo-ku Tokyo 113-8421 (Japan)

Tel. +81 3 5802 1037, Fax +81 3 3812 1056, E-Mail [email protected]

Was this article helpful?

0 0

Post a comment